Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | TLR2 | O60603 | 3/20 | 0.50 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.48 |
| ▸ | MDM4 | O15151 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16329206 | 0.92 | KMT2A (0.53) | KMT2ATLR2MDM2MDM4TP53 | |
| SCHEMBL15750412 | 0.92 | KMT2A (0.53) | KMT2ATLR2MDM2MDM4TP53 | |
| SCHEMBL31522724 | 0.92 | KMT2A (0.53) | KMT2ATLR2MDM2MDM4TP53 | |
| SCHEMBL13495919 | 0.91 | KMT2A (0.61) | KMT2ATLR2MDM2MDM4TP53 | |
| SCHEMBL17919592 | 0.91 | KMT2A (0.61) | KMT2ATLR2MDM2MDM4TP53 | |
| SCHEMBL30693894 | 0.91 | KMT2A (0.51) | KMT2ATLR2MDM2 | |
| SCHEMBL178698 | 0.90 | KMT2A (0.66) | KMT2ATLR2MDM2MDM4TP53 | |
| SCHEMBL260631 | 0.90 | KMT2A (0.66) | KMT2ATLR2MDM2MDM4TP53 | |
| SCHEMBL178733 | 0.90 | KMT2A (0.66) | KMT2ATLR2MDM2MDM4TP53 | |
| SCHEMBL29359997 | 0.90 | KMT2A (0.66) | KMT2ATLR2MDM2MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100331489-A1 | BRANCHED WATER-SOLUBLE POLYMERS AND THEIR CONJUGATES | BIOGENERIX AG (DE) | 2010-12-30 | — | — | US | disclosed |
| US-7803777-B2 | Branched water-soluble polymers and their conjugates | BIOGENERIX AG (DE) | 2010-09-28 | — | — | US | disclosed |
| US-20080319183-A1 | Branched Polymeric Sugars and Nucleotides Thereof | NEOSE TECHNOLOGIES, INC. (US) | 2008-12-25 | — | — | US | disclosed |
| US-20070032405-A1 | Branched water-soluble polymers and their conjugates | NEOSE TECHNOLOGIES, INC. (US) | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319183-A1 | Branched Polymeric Sugars and Nucleotides Thereof | GALE, NUDT14, GNE | KMT2A 3676/4885TLR2 440/4885MDM2 2963/4885 |
| US-20100331489-A1 | BRANCHED WATER-SOLUBLE POLYMERS AND THEIR CONJUGATES | SLC7A5, SLC43A1, SLC7A1 | KMT2A 3771/4885TLR2 904/4885MDM2 1844/4885 |
| US-20070032405-A1 | Branched water-soluble polymers and their conjugates | SLC7A5, SLC43A1, SLC7A1 | KMT2A 3771/4885TLR2 904/4885MDM2 1844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.